Forte Biosciences, Inc. (FBRX)
NASDAQ·Healthcare·Biotechnology
$17.81
+2.33%
Mkt Cap $264.80M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$65.00
Range $65.00 – $65.00
Implied Upside
+265.1%
Consensus $65.00 vs current $17.81
NASDAQ·Healthcare·Biotechnology
$17.81
+2.33%
Mkt Cap $264.80M
No recent rating data.
Price Target (1 analysts)
$65.00
Range $65.00 – $65.00
+265.1%
Consensus $65.00 vs current $17.81